Earnings call Dr. Lal PathLabs reported Q3 FY25 revenue of ₹597 crore, up 10.7% YoY, with EBITDA margin at 25.8% and PAT up 19.3% YoY. Growth was driven by volume gains, improved mix, and Swasthfit ...

This page features the latest DR LAL PATH LABS F share stories and breaking news. Assess the latest information about the DR LAL PATH LABS F stock. Our team of expert financial journalists are ready ...

Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

Dr. Lal Path Labs posts earnings dip on Indian labour code changes; test demand strong Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to ...

Discover Dr Lal Path Labs diagnostic services in New Delhi, Delhi. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information on ...

Stock market performance on Wednesday was fueled by the mixed reaction of investors who were cautious of US market uncertainties, declining oil prices, bond yields, and bullion. The stock market ended ...

When my father, Dr SK Lal, decided to make India his country at the time of Partition, and came to Delhi from Rawalpindi, he had 31 dependents with him," recalls (Hony) Brigadier Dr Arvind Lal, ...

(Reuters) -Dr Lal Path Labs, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid ...

Earnings call Dr. Lal PathLabs reported Q1FY26 revenue of ₹670 crore, up 11.3% YoY, and PAT of ₹134 crore, up 24.3% YoY. EBITDA margin stood at 28.7%. Management reaffirmed 11–12% revenue growth ...